Wednesday, 26 January 2022

 

 

LATEST NEWS Lt Governor Manoj Sinha hoists National Flag at Republic Day function Patriotic spirit, festivity mark Republic day celebrations across Jammu division 73rd Republic Day celebrations held across Kashmir Educational Institutions, Govt deptts organise flag hoisting, other activities to celebrate R-Day Advisor Rajeev Rai Bhatnagar unfurls National Flag on Republic Day at SK Stadium, Srinagar Horticulture Department celebrates 73rd Republic Day Div Com Kashmir unfurls National Flag; takes salute Justice Magrey unfurls National Flag, takes salute at High Court of J&K, Ladakh, Srinagar Wing Principal Resident Commissioner Unfurls Tricolor at JK House CJ hoists tricolour at Jammu complex of the High Court In view of the decisions taken by the PM, India's identity has been made in the world, Haryana has made unprecedented progress in various fields : Anil Vij Many people contributed in the freedom struggle : Anil Vij ADC Nayan exhorts youth to play proactive role in making India a vibrant and progressive republic State Level Republic Day Function Held At Mohali 73rd Republic Day celebrated with enthusiasm in Himachal Charanjit Singh Channi Calls Doaba, Heartland Of Martyrs, Unfurls National Tricolour On 73rd Republic Day Will make Punjab the safest state of our country : Bhagwant Mann Congress used Channi as part of its 'Use & Throw' policy : Raghav Chadha Study explores ways to get super immunity against Covid-19 'Pebbles' wins Best Film award at 20th Dhaka International Film Festival Sophie Molineux ruled out as Wellington and King included in Australia's World Cup squad

 

Johnson & Johnson Covid-19 vaccine benefits 'far outweigh' risks: CDC

Coronavirus, COVID 19, Covaxin, Covishield, Covid-19 Vaccine, Sputnik V, Pfizer, Astra Zeneca, Remdesivir, Covifor, Johnson & Johnson Covid-19 vaccine, Centers for Disease Control and Prevention, CDC, Food and Drug Administration, Delta Plus Covid variant, Delta Covid-19 variant

Web Admin

Web Admin

5 Dariya News

Washington , 23 Jul 2021

The benefits of the Johnson & Johnson Covid-19 vaccine far outweigh its potential risks amid an ongoing review of reports of a rare neurological disorder, according to an advisory panel to the US Centers for Disease Control and Prevention (CDC) on Thursday.There have been 8.1 cases of Guillain-Barre syndrome per 1 million doses, which is higher than expected in the general population and close to eight times the rate seen in Pfizer's and Moderna's shots, according to data presented at a meeting of CDC's Advisory Committee on Immunization Practices on Thursday.Guillain-Barre is a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis, according to the US Food and Drug Administration (FDA).The data came after the US Food and Drug Administration (FDA) announced a new warning on July 12 for the Johnson & Johnson shot after preliminary reports of Guillain-Barre syndrome in some recipients, the Xinhua news agency reported.About 100 preliminary reports of Guillain-Barre syndrome have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson vaccine in the US, according to the FDA.Of these reported cases, 95 were serious and required hospitalisation, and one was dead.

 

Tags: Coronavirus , COVID 19 , Covaxin , Covishield , Covid-19 Vaccine , Sputnik V , Pfizer , Astra Zeneca , Remdesivir , Covifor , Johnson & Johnson Covid-19 vaccine , Centers for Disease Control and Prevention , CDC , Food and Drug Administration , Delta Plus Covid variant , Delta Covid-19 variant

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD